For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260605:nRSE1000Ha&default-theme=true
RNS Number : 1000H Iofina PLC 05 June 2026
5 June 2026
Iofina plc
("Iofina", the "Company" or the "Group")
(AIM: IOF)
Agreement Signed for Additional Brine Water Supply to Plant IO#11
Iofina plc (AIM: IOF), specialists in the exploration and production of iodine
and manufacturers of specialty chemical products, is pleased to announce that
it has signed an agreement with a new brine water supply partner to provide
additional brine water to its IOsorb® plant, IO#11 ("the Project"), located
in Central Oklahoma, which became operational in July 2025.
As a result of this agreement, the plant will be serviced by two independent
brine supply partners. The existing facility has sufficient installed capacity
to process the additional brine volumes and extract iodine from the new
source. The additional brine water is expected to increase crystalline iodine
production between 45 and 65 metric tonnes annually at this site once fully
operational.
Under the terms of the agreement, Iofina will work with the new partner to
construct a pipeline system to transport the brine water to IO#11 and return
the brine without iodine back to their disposal site. The financing of the
Project will be approximately US$1.5 million and will be fully funded by the
Company, as the Group anticipates a rapid payback on this investment. This
investment will increase annual production at IO#11 by approximately 50%.
Construction for the Project will mostly be managed by our new partner, with
preliminary expectations to be completed in Q3 2026.
The Board believes this agreement represents a highly efficient growth
opportunity that leverages existing assets and infrastructure while enhancing
the long-term production profile of the Central Oklahoma facility.
President and CEO, Dr. Tom Becker, commented:
"We are pleased to announce this new agreement, which increases the production
potential of our most recently opened plant, IO#11, in Central Oklahoma. By
adding an additional brine water source to an existing facility with available
capacity, we will be able to deliver incremental iodine production. Iofina is
optimising production at IO#11 concurrently with the construction of our first
plant in the Permian Basin. We remain committed to maximising value from our
current operating footprint, as well as achieving substantial new iodine
production growth."
Enquiries:
Iofina plc
Dr. Tom Becker
CEO & President
Tel: +44 (0)20 3006 3135
Nomad & Broker:
Canaccord Genuity Limited
Henry Fitzgerald-O'Connor/Harry Rees
Tel: +44 (0)20 7523 8000
Financial PR and Media Contact:
Yellow Jersey PR Limited
Charles Goodwin/Shivantha Thambirajah/Maya Brookes
Tel: +44 (0)7747 788 221/+44 (0)7983 521 488
About Iofina:
Iofina plc (AIM: IOF) is a vertically integrated company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.
LEI: 213800QDMFYVRJYYTQ84
ISIN: GB00B2QL5C79
Iofina Resources
Iofina Resources develops, builds, owns, and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina operates eight IOsorb®
plants in Oklahoma and consistently uses technology and innovation to improve
and expand its operations. A ninth plant is under construction in the Permian
Basin.
Iofina Chemical
Iofina Chemical has manufactured high-quality halogen speciality chemicals
derived from raw iodine, as well as non-iodine-based products. Iofina
Chemical celebrated its 40(th) anniversary in 2023 as a preeminent
halogen-based specialty chemicals company.
www.iofina.com (http://www.iofina.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END AGRFIMFTMTTMBPF
Copyright 2019 Regulatory News Service, all rights reserved